Halozyme Therapeutics Inc. Common Stock vs Regions Financial Corporation Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.94 (market cap $12.58B), while Regions Financial Corporation Common Stock trades at $27.04 (market cap $23.06B). The key difference: Regions Financial Corporation Common Stock is the larger of the two by market cap, and Regions Financial Corporation Common Stock pays a 4.05% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Regions Financial Corporation Common Stock for 0 Days on average.
| HALO | RF | |
|---|---|---|
Market Cap | $12.58B | $23.06B |
Volume | 2,179,278 | 13,190,101 |
Sector | Health | Financials |
52-Week High | $115.22 | $32.40 |
52-Week Low | $61.63 | $23.35 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $20.80B |
Dividend Yield | — | 4.05% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Regions Financial is a financial holding company that operates through Regions Bank. It provides consumer, commercial, mortgage, wealth-management, and investment services across the South, Midwest, and Texas.
Read more on RF →